Release Date: 09/12/11 10:07 Summary: Malilongue Due Diligence and Acquisition Complete Price Sensitive: Yes Download Document 692.48KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%